Relievant Medsystems Announces Positive Local Coverage Determination by Palmetto GBA for Basivertebral Nerve Ablation in Treating Chronic Vertebrogenic Low Back Pain
Tyler Binney, President and CEO of Relievant Medsystems. “We are pleased that Palmetto GBA recognized the strong clinical evidence supporting the Intracept Procedure and we remain dedicated to educating payers about the life-changing outcomes of this therapy.”